Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pharmacotherapy for Prevention and Management of Thrombosis in Covid-19 Publisher Pubmed



Hashemi A1 ; Madhavan MV2, 3 ; Bikdeli B3, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Division of Cardiology, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY, United States
  3. 3. Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, United States
  4. 4. Section of Vascular Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
  5. 5. Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, United States

Source: Seminars in Thrombosis and Hemostasis Published:2020


Abstract

[No abstract available]
Other Related Docs
13. Covid-19 and Cardiovascular Diseases, Advances in Experimental Medicine and Biology (2021)
15. Covid-19: General Strategies for Herbal Therapies, Journal of Evidence-Based Integrative Medicine (2022)
21. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
23. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
29. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
32. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
35. A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus, Archives of Clinical Infectious Diseases (2020)
39. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
46. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)